1. Home
  2. WST vs COO Comparison

WST vs COO Comparison

Compare WST & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo West Pharmaceutical Services Inc.

WST

West Pharmaceutical Services Inc.

HOLD

Current Price

$267.35

Market Cap

18.5B

Sector

Health Care

ML Signal

HOLD

Logo The Cooper Companies Inc.

COO

The Cooper Companies Inc.

HOLD

Current Price

$71.62

Market Cap

16.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WST
COO
Founded
1923
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Ophthalmic Goods
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.5B
16.5B
IPO Year
2004
1994

Fundamental Metrics

Financial Performance
Metric
WST
COO
Price
$267.35
$71.62
Analyst Decision
Buy
Buy
Analyst Count
7
11
Target Price
$319.43
$90.18
AVG Volume (30 Days)
757.6K
1.6M
Earning Date
04-23-2026
05-28-2026
Dividend Yield
0.34%
N/A
EPS Growth
1.49
N/A
EPS
6.79
0.66
Revenue
$2,886,900,000.00
$2,532,800,000.00
Revenue This Year
$6.76
$6.66
Revenue Next Year
$6.25
$5.20
P/E Ratio
$38.21
$108.64
Revenue Growth
1.95
18.41
52 Week Low
$193.05
$61.78
52 Week High
$322.34
$89.83

Technical Indicators

Market Signals
Indicator
WST
COO
Relative Strength Index (RSI) 65.12 44.71
Support Level $262.93 $70.97
Resistance Level $278.04 $75.24
Average True Range (ATR) 7.02 1.62
MACD 1.71 0.54
Stochastic Oscillator 98.19 74.30

Price Performance

Historical Comparison
WST
COO

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About COO The Cooper Companies Inc.

CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.

Share on Social Networks: